Dubai - Mubasher: Hikma Pharmaceuticals reported a 38% year-on-year decline in profits in the first half of 2016 to $59 million, compared to $135 million in the same period last year.
In the six-month period that ended 30 June 2016, the company’s revenues increased 25%, while total expenses increased 51.2%, according to the company’s statement.
